Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology

Toxicon

Volumn 56, Issue 3, 2010, Pages 373-380

  Cook, Darren A N ^a   Owen, Timothy ^a   Wagstaff, Simon C ^a   Kinne, Joerg ^b   Wernery, Ulrich ^b   Harrison, Robert A ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b CENTRAL VETERINARY RESEARCH LABORATORY   (United Arab Emirates)

Author keywords

Bitis arietans; Camelid IgG; Echis ocellatus; ED50 preclinical assay; Naja nigricollis; Snake antivenom; Venom

Indexed keywords

ECHITABG; IMMUNOGLOBULIN G; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG;

AFRICA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; ARTIODACTYLA; BINDING AFFINITY; BLEEDING; BLOOD CLOTTING DISORDER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; ENVENOMATION; FEMALE; HORSE; LETHALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEEP; SNAKE; SPECIES DIFFERENCE;

ANIMALS; ANTIBODIES; ANTIVENINS; CAMELS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; NEUTRALIZATION TESTS; SNAKE VENOMS;

BITIS ARIETANS; CAMELIDAE; ECHIS; ECHIS CARINATUS; ECHIS OCELLATUS; EQUIDAE; MAMMALIA; NAJA NIGRICOLLIS; OVIS;

EID: 77954144511     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.04.005     Document Type: Article

References (37)

1. Abubakar S.B., Abubakar I.S., Habib A.G., Nasidi A., Durfa N., Yusuf P.O., Larnyang S., Garnvwa J., Sokomba E., Salako L., Laing G.D., Theakston R.D.G., Juszczak E., Alder N., Warrell D.A. Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria. Toxicon 2010, 55(4):719-723.
2. Borrow R., Andrews N., Goldblatt D., Miller E. Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infection and Immunity 2001, 69(3):1568-1573.
3. British Pharmacopoeia Antisera: European Viper Antivenom 2002, 2560. second ed.
4. Casasola A., Ramos-Cerrillo B., de Roodt A.R., Saucedo A.C., Chippaux J.-P., Alagon A., Stock R.P. Paraspecific neutralization of the venom of African species of cobra by an equine antiserum against Naja melanoleuca: a comparative study. Toxicon 2009, 53(6):602-608.
5. Chinonavanig L., Billings P.B., Matangkasombut P., Ratanabanangkoon K. Antigenic relationships and relative immunogenicities of venom proteins from six poisonous snakes of Thailand. Toxicon 1988, 26(9):883-890.
6. Chotwiwatthanakun C., Pratanaphon R., Akesowan S., Sriprapat S., Ratanabanangkoon K. Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol. Toxicon 2001, 39(10):1487-1494.
7. Cook, D.A.N., Owen, T., Wagstaff, S.W., Kinne, J., Wernery, U., Harrison, R.A. Analysis of camelid IgG for antivenom development: serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa. Toxcon, in press.
8. Einterz E.M., Bates M.E. Snakebite in northern Cameroon: 134 victims of bites by the saw-scaled orcarpet viper, Echis ocellatus. Transactions of the Royal Society of Tropical Medicine and Hygiene 2003, 97(6):693-696.
9. Finney D.J. Probit Analysis 1971, Cambridge University Press, Cambridge.
10. Goldblatt D., Borrow R., Miller E. Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults. Journal of Infectious Diseases 2002, 185(3):397-400.
11. Gutierrez J.M., Rojas E., Quesada L., Leon G., Nunez J., Laing G.D., Sasa M., Renjifo J.M., Nasidi A., Warrell D.A., Theakston R.D.G., Rojas G. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 2005, 99(6):468-475.
12. Gutierrez J.M., Rucavado A., Escalante T., Lomonte B., Angulo Y., Fox J.W. Tissue pathology induced by snake venoms: how to understand a complex pattern of alterations from a systems biology perspective?. Toxicon 2010, 55:166-170.
13. Harrison R.A., Hasson S.S., Harmsen M., Laing G.D., Conrath K., Theakston R.D.G. Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera. Toxicon 2006, 47(3):364-368.
14. Harrison R.A., Hargreaves A., Wagstaff S.C., Faragher B., Lalloo D.G. Snake envenoming: a disease of poverty. PLoS Neglected Tropical Diseases 2009, 3(12):e569.
15. Herrera M., Leon G., Segura A., Meneses F., Lomonte B., Chippaux J.P., Gutierrez J.M. Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs. Toxicon 2005, 46(7):775-781.
16. Kamiguti A.S., Zuzel M., Theakston R.D.G. Snake venom metalloproteinases and disintegrins: interactions with cells. Brazilian Journal of Medical and Biological Research 1998, 31(7):853-862.
17. Kasturiratne A., Wickremasinghe A.R., de Silva N., Gunawardena N.K., Pathmeswaran A., Premaratna R., Savioli L., Lalloo D.G., de Silva H.J. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Medicine 2008, 5(11):1591-1604.
18. Laing G.D., Lee L., Smith D.C., Landon J., Theakston R.D.G. Experimental assessment of a new, low-cost antivenom for treatment of carpet viper (Echis-Ocellatus) envenoming. Toxicon 1995, 33(3):307-313.
19. Laing G.D., Renjifo J.M., Ruiz F., Harrison R.A., Nasidi A., Gutierrez J.M., Rowley P.D., Warrell D.A., Theakston R.D.G. A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa. Toxicon 2003, 42(1):35-41.
20. Laing G.D., Theakston R.D.G., Leite R.P., Dias da Silva W.D., Warrell D.A., BIASG Comparison of the potency of three Brazilian Bothrops antivenoms using in vivo rodent and in vitro assays. Toxicon 1992, 30(10):1219-1225.
21. Lauwereys M., Ghahroudi M.A., Desmyter A., Kinne J., Holzer W., De Genst E., Wyns L., Muyldermans S. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO Journal 1998, 17(13):3512-3520.
22. Pratanaphon R., Akesowan S., Khow O., Sriprapat S., Ratanabanangkoon K. Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia). Vaccine 1997, 15(14):1523-1528.
23. Pugh R.N.H., Theakston R.D.G. Incidence and mortality of snake bite in Savanna Nigeria. Lancet 1980, 2(8205):1181-1183.
24. Rungsiwongse J., Ratanabanangkoon K. Development of an ELISA to assess the potency of horse therapeutic antivenom against Thai cobra venom. Journal of Immunological Methods 1991, 136(1):37-43.
25. Segura A., Villalta M., Herrera M., Leon G., Harrison R., Durfa N., Nasidi A., Calvete J.J., Theakston R.D.G., Warrell D.A., Gutierrez J.M. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa. Toxicon 2010, 55(2-3):369-374.
26. Sunthornandh P., Matangkasombut P., Ratanabanangkoon K. Preparation, characterization and immunogenicity of various polymers and conjugates of elapid postsynaptic neurotoxins. Molecular Immunology 1992, 29(4):501-510.
27. Theakston R.D.G., Laing G.D., Fielding C.M., Lascano A.F., Touzet J.-M., Vallejo F., Guderian R.H., Nelson S.J., Wuster W., Richards A.M., Guzman J.R., Warrell D.A. Treatment of snake bites by Bothrops species and Lachesis muta in Ecuador: laboratory screening of candidate antivenoms. Transactions of the Royal Society of Tropical Medicine and Hygiene 1995, 89(5):550-554.
28. Theakston R.D.G., Reid H.A. Development of simple standard assay procedures for the characterization of snake venoms. Bulletin of the World Health Organization 1983, 61(6):949-956.
29. Theakston R.D.G., Warrell D.A. Crisis in snake antivenom supply for Africa. Lancet 2000, 356(9247):2104.
30. Trape J.F., Pison G., Guyavarch E., Mane Y. High mortality from snakebite in south-eastern Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene 2001, 95(4):420-423.
31. Waghmare A., Deopurkar R.L., Salvi N., Khadilkar M., Kalolikar M., Gade S.K. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom. Vaccine 2009, 27(7):1067-1072.
32. Warrell D.A., Arnett C. The importance of bites by the saw-scaled or carpet viper (Echis carinatus): epidemiological studies in Nigeria and a review of world literature. Acta Tropica 1976, 33(4):307-341.
33. Warrell D.A., Davidson N.M., Greenwood B.M., Ormerod L.D., Pope H.M., Watkins B.J., Prentice C.R.M. Poisoning by bites of saw-scaled or carpet viper (Echis carinatus) in Nigeria. Quarterly Journal of Medicine 1977, 46(181):33-62.
34. Warrell D.A., Greenwood B.M., Davidson N.M., Ormerod L.D., Prentice C.R.M. Necrosis, Hemorrhage and complement depletion following bites by spitting cobra (Naja nigricollis). Quarterly Journal of Medicine 1976, 45(177):1-22.
35. Warrell D.A., Looareesuwan S., Theakston R.D.G. Randomized comparative trial of three monospecific antivenoms for bites by the Malayan pit viper (Calloselasma rhodostoma) in southern Thailand: clinical and laboratory correlations. American Journal of Tropical Medicine and Hygiene 1986, 35(6):1235-1247.
36. Warrell D.A., Ormerod L.D., Davidson N.M. Bites by Puff-adder (Bitis arietans) in Nigeria, and value of antivenom. British Medical Journal 1975, 4(5998):697-700.
37. WHO Progress in the characterization of venoms and standardization of antivenoms. World Health Organization Offset Publication 1981, 58:1-44.